Stem Cell Stocks 5/31/09: The Week That Was

Last week consisted of more sporadic trading for the stem cell stocks. I'm still trying to figure out if there is some correlation between the general market and the stem cell sector, but as of right now, nothing stands out.

Top Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Up 47% for the week; Mid-week ISCO.OB received positive early results from animal trials designed to improve photorefractive keratectomy (PRK), a form of corrective laser eye surgery that offers an improved alternative to LASIK.

Worst Stem Cell Stock Performer(s) for Last Week:

Cord Blood America Inc. (CBAI.OB) = Down -15%; This stock was flat all week and then tanked the last hour of the last trading day of the week. It looks like frustrated traders are throwing in the towel.

Stem Cell Stocks Current Price and % Up or Down 5/25/09 - 5/29/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.50; Up 8%
Aastrom Biosciences (ASTM) = Cur Price: $0.335; Down -7%
BioTime, Inc. (BTIM) = Cur Price: $2.55; Down -3%
Celgene Corp (CELG) = Cur Price: $42.24; Up 7%
Cytori Therapeutics (CYTX) = Cur Price: $3.79; Up 32%
Geron Corp (GERN) = Cur Price: $6.52; Down -4%
ThermoGenesis (KOOL) = Cur Price: $0.53; Down -4%
Osiris Therapeutics (OSIR) = Cur Price: $12.61; Up 5%
StemCell Inc. (STEM) = Cur Price: $1.63; Down -3%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.148; Up 14%
Athersys Inc. (ATHX) = Cur Price: $0.84; Down -6%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Down -8%
Bioheart Inc. (BHRT) = Cur Price: $0.84; Down -7%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0041; Down -15%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.25; Up 9%
Neuralstem (CUR) = Cur Price: $1.05; Down -5%
International Stem Cell (ISCO.OB) = Cur Price: $1.00; Up 47%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0165; Up 38%
Pluristem Therapeutics (PSTI) = Cur Price: $1.24; Up 7%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.06; Down -8%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.048; Down -4%

Catalyst(s):

Nothing has changed from the last few months.

- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.

Stem Cell Stocks 5/24/09: The Week That Was

It was flat week for the most part for the stem cell stocks. Overall, the stocks that have fallen the hardest in the sector have finally begun to level out. As a result, now may finally be the time to consider buying select names in the sector. The only stem cell stock that has shown consistent upward movement over the last 3 months has been Geron Corp. (GERN).







Top Stem Cell Stock Performer(s) for Last Week:

- Bioheart Inc. (BHRT.OB) = Up 38%; The low volume continues to yield wild swings. If you recall, Bioheart was the worst performer of the group the previous week.



Worst Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Down -22% for the week; With ISCO.OB being the best performer the previous week, we mentioned that it would be a good stock to short due to profit taking. It looks like we were right.

Stem Cell Stocks Current Price and % Up or Down 5/18/09 - 5/22/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.39; Unchanged
Aastrom Biosciences (ASTM) = Cur Price: $0.36; Down -3%
BioTime, Inc. (BTIM) = Cur Price: $2.64; Up 2%
Celgene Corp (CELG) = Cur Price: $39.43; Down -1%
Cytori Therapeutics (CYTX) = Cur Price: $2.88; Up 3%
Geron Corp (GERN) = Cur Price: $6.79; Up 8%
ThermoGenesis (KOOL) = Cur Price: $0.553; Down -3%
Osiris Therapeutics (OSIR) = Cur Price: $12.02; Down -3%
StemCell Inc. (STEM) = Cur Price: $1.68; Down -4%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.13; Down -7%
Athersys Inc. (ATHX) = Cur Price: $0.89; Up 9%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.076; Down -5%
Bioheart Inc. (BHRT) = Cur Price: $0.90; Up 38%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0048; Down -13%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.15; Down -4%
Neuralstem (CUR) = Cur Price: $1.10; Down -7%
International Stem Cell (ISCO.OB) = Cur Price: $0.68; Down -22%
MultiCell Technologies (MCET.OB) = Cur Price: $0.012; Up 14%
Pluristem Therapeutics (PSTI) = Cur Price: $1.16; Down -19%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.065; Unchanged
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.05; Up 2%

Catalyst(s) for the Week:

Nothing has changed from the last few months.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 5/17/09: The Week That Was

If you remember back to when the market was in its tailspin, one of the only plays that seemed to work were the stem cell stocks. With the overall market currently in a bit of a slide, it was interesting to see if the sector would again be a strong performer. However, nothing much has changed. The only upward movement has come from those individual stocks with news or out of the blue trading momentum.

Top Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Up 98% for the week; This stock acted very unusual last week. At one point the stock nearly tripled. Shares spiked on 8 times the average volume on four consecutive trading days. Friday it finally pulled back. All this movement occurred with no news. It looks like a huge short opportunity if you're into that.

Worst Stem Cell Stock Performer(s) for Last Week:

- Bioheart Inc. (BHRT.OB) = Down -24%; Stock has very low volume. Swings of this sort are not uncommon

Stem Cell Stocks Current Price and % Up or Down 5/11/09 - 5/15/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.39; Up 5%
Aastrom Biosciences (ASTM) = Cur Price: $0.37; Down -6%
BioTime, Inc. (BTIM) = Cur Price: $2.60; Up 37%
Celgene Corp (CELG) = Cur Price: $39.79; Down -4%
Cytori Therapeutics (CYTX) = Cur Price: $2.80; Up 12%
Geron Corp (GERN) = Cur Price: $6.26; Up 1%
ThermoGenesis (KOOL) = Cur Price: $0.57; Up 6%
Osiris Therapeutics (OSIR) = Cur Price: $12.35; Down -7%
StemCell Inc. (STEM) = Cur Price: $1.75; Up 3%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.14; Up 43%
Athersys Inc. (ATHX) = Cur Price: $0.82; Unchanged
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.08; Up 14%
Bioheart Inc. (BHRT) = Cur Price: $0.65; Down -24%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0055; Down -4%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.20; Down -15%
Neuralstem (CUR) = Cur Price: $1.18; Down -2%
International Stem Cell (ISCO.OB) = Cur Price: $0.87; Up 98%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0105; Up 4%
Pluristem Therapeutics (PSTI) = Cur Price: $1.44; Up 9%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.065; Down -4%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.049; Up 26%

Catalyst(s) for the Week:

Nothing has changed from the last few months.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 5/10/09: The Week That Was

Only individual names in the stem cell sector moved this week. Names like GERN and CCEL have impressive charts over the last month, but we have still yet to see that large group move like earlier in the year. Look for there to be continued sporadic movement in the sector.

Top Stem Cell Stock Performer(s) for Last Week:

- Cytori Therapeutics (CYTX) = Up 37% for the week; They announced an agreement by which GE Healthcare will commercialize Cytori’s StemSource® technology in the North American stem cell banking and research markets.

Worst Stem Cell Stock Performer(s) for Last Week:

- ThermoGenesis Corp (KOOL) = Down -19%; Got hammered for reporting 2009 revenue outlook below analyst estimates.

Stem Cell Stocks Current Price and % Up or Down 5/4/09 - 5/8/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.32; Down -11%
Aastrom Biosciences (ASTM) = Cur Price: $0.394; Up 4%
BioTime, Inc. (BTIM) = Cur Price: $1.90; Down -2%
Celgene Corp (CELG) = Cur Price: $41.42; Up 5%
Cytori Therapeutics (CYTX) = Cur Price: $2.50; Up 37%
Geron Corp (GERN) = Cur Price: $6.23; Up 22%
ThermoGenesis (KOOL) = Cur Price: $0.54; Down -19%
Osiris Therapeutics (OSIR) = Cur Price: $13.35; Up 7%
StemCell Inc. (STEM) = Cur Price: $1.70; Up 2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.098; Down -1%
Athersys Inc. (ATHX) = Cur Price: $0.82; Up 1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Down -5%
Bioheart Inc. (BHRT) = Cur Price: $0.85; Up 9%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0057; Up 6%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.42; Up 15%
Neuralstem (CUR) = Cur Price: $1.21; Up 5%
International Stem Cell (ISCO.OB) = Cur Price: $0.44; Down -6%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0101; Down -8%
Pluristem Therapeutics (PSTI) = Cur Price: $1.32; Down -13%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.068; Down -9%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.039; Unchanged

Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 5/3/09: The Week That Was

As expected, the stem cell stocks still did not move this week. A couple of stocks with connections to cancer or the flu moved early in the week, but gave up their gains. Look for there to be continued sporadic movement in the sector.

Top Stem Cell Stock Performer(s) for Last Week:
- Cryo-Cell International (CCEL) = Up 54% for the week; This stock stock has more than doubled in the last 2 1/2 weeks. The rise is began shortly after an earnings report that pointed to a bright future. Look for a pull back shortly.


Worst Stem Cell Stock Performer(s) for Last Week:

- Stem Cell Therapy Intl (SCII) = Down -21% for the week on average volume; No significant news; not out of the ordinary for a penny stock

Stem Cell Stocks Current Price and % Up or Down 4/27/09 - 5/01/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.49; Down -2%
Aastrom Biosciences (ASTM) = Cur Price: $0.38; Up 17%
BioTime, Inc. (BTIM) = Cur Price: $1.94; Down -11%
Celgene Corp (CELG) = Cur Price: $39.54; Down -1%
Cytori Therapeutics (CYTX) = Cur Price: $1.82; Up 2%
Geron Corp (GERN) = Cur Price: $5.10; Up 3%
ThermoGenesis (KOOL) = Cur Price: $0.67; Up 14%
Osiris Therapeutics (OSIR) = Cur Price: $12.42; Up 1%
StemCell Inc. (STEM) = Cur Price: $1.66; Up 2%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.099; Down -1%
Athersys Inc. (ATHX) = Cur Price: $0.81; Up 1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.074; Down -8%
Bioheart Inc. (BHRT) = Cur Price: $0.78; Up 13%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0054; Down -2%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.23; Up 54%
Neuralstem (CUR) = Cur Price: $1.15; Down -3%
International Stem Cell (ISCO.OB) = Cur Price: $0.47; Down -10%
MultiCell Technologies (MCET.OB) = Cur Price: $0.011; Up 10%
Pluristem Therapeutics (PSTI) = Cur Price: $1.52; Up 14%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.075; Down -21%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.039; Down -5%

Catalyst(s) for the Week:

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.